COVID-19: Rapid response and financial impact for the IVD industry

The COVID-19 pandemic has turned a spotlight on the In Vitro Diagnostics (IVD) industry, with rapid development of diagnostics, fast-tracked regulatory clearances and ramped up distribution in various regions to help curb the spread of the virus. In this executive summary we look at the market impacts and challenges for the IVD industry and what the future might hold.